Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma-Reference-Cited by-同舟云学术

Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma

Published:2018-06 Issue:6 Volume:26 Page:1482-1493
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ligtenberg Maarten A.,Pico de Coaña Yago,Shmushkovich Taisia,Yoshimoto Yuya,Truxova Iva,Yang Yuan,Betancur-Boissel Monica,Eliseev Alexey V.,Wolfson Alexey D.,Kiessling Rolf

Funder

NIH

The Swedish Cancer Society

The Cancer Society in Stockholm

The King Gustaf V’s Jubilee Foundation

The Swedish Medical Research Council

Stockholm City Council

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference59 articles.

1. Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies;Besser;Clin. Cancer Res.,2013

2. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin. Cancer Res.,2011

3. Adoptive cell transfer as personalized immunotherapy for human cancer;Rosenberg;Science,2015

4. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen;Johnson;Blood,2009

5. Chimeric antigen receptors: a cell and gene therapy perspective;Rivière;Mol. Ther.,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bi-adjuvant nanovaccine amplifying STING activation for cancer immunotherapy;Nano Today;2024-08

2. Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage;Molecular Pharmaceutics;2024-04-17

3. Systematic optimization of siRNA productive uptake into resting and activated T cells ex vivo;Biomedicine & Pharmacotherapy;2024-03

4. Injectable hydrogels for personalized cancer immunotherapies;Acta Biomaterialia;2023-12

5. Systematic optimization of siRNA productive uptake into resting and activated T cellsex vivo;2023-10-20